Key result
Implantable loop recorders capture resyncope in ~75% of pediatric patients to clarify arrhythmic origins.
Why the study?
Recurrent but infrequent syncopes in children often remain unexplained despite extensive investigations, and experience with implantable loop recorders in this population is limited.
Does an implantable loop recorder improve the diagnosis of recurrent syncope in children and adolescents?
Observational (n=12)
No
Does an implantable loop recorder improve the diagnosis of recurrent syncope in children and adolescents?
Implantable loop recorders are a safe and effective diagnostic tool for identifying or ruling out arrhythmic causes of recurrent syncope in high-risk children and adolescents.
Answers are grounded in this paper and cite their sources.
May aid syncope diagnosis in high-risk children; hypothesis-generating and should not yet change practice.
INTRODUCTION: Recurrent but infrequent syncopes represent a diagnostic challenge, since they frequently remain unexplained despite extensive investigations. This applies specifically for patients who carry an increased risk of potentially lifethreatening arrhythmias, either due to congenital cardiac disease or primary electrical disorders. Implantable loop recorders permit long-term electrocardiographic monitoring. Experience with these devices is still limited in children. PATIENTS AND METHODS: Between January 1999 and August 2005, 12 patients underwent implantation of a loop recorder in our tertiary referral centre. The mean age was 10.9 years, with a range from 2 to 17 years. Of the patients, 6 had structural disease, 3 had primary electrical abnormalities, and 3 had no cardiovascular disease. RESULTS: Resyncope occured in 9 of the 12 patients. Arrhythmic origin of the syncope was diagnosed in 4 of these patients. The events recorded were ventricular fibrillation in 2, intermittent asystole in 1, and pacemaker-syndrome in the other patient. Malignant arrhythmia was ruled out in the remaining 5 patients. There were no complications related to implantation of the loop recorder, and the mean duration until explantation was 8.3 months. CONCLUSIONS: Based on our experience, we suggest that implantation of a loop recorder represents an additional tool for a selected group of children. Due to its invasive nature, it should be restricted to patients at high risk, or those in which there is substantial clinical suspicion of the likelihood of serious arrhythmias when conventional testing has been inconclusive. In this cohort, implantation of the loop recorder either helps to establish the correct diagnosis, or to exclude an arrhythmic event, thus avoiding unnecessary escalation of therapy and providing reassurance for the family.
No takes yet. Share an insight, caveat, or question.
Gass et al. (2006) conducted an observational in Recurrent but infrequent syncopes (n=12). Implantable loop recorder was evaluated on Resyncope. Implantable loop recorders documented resyncope in 75% (9 of 12) of pediatric patients, establishing an arrhythmic origin in 4 and ruling out malignant arrhythmia in 5.
Synapse has enriched 10 related papers. Consider them for comparative context: